Independent cost guide · Thailand · 2026

How Much Does Peptide Therapy Cost in Thailand?

For legally eligible, doctor-prescribed treatments, peptide therapy in Thailand typically runs from about ฿3,500 to ฿45,000 per month depending on the peptide and program. These are indicative market ranges, not fixed clinic prices, with consultation and nationwide delivery included where clinically and legally appropriate.

Key Takeaways

  • Indicative Thailand market ranges for peptide therapy are about ฿3,500 to ฿45,000 per month, not fixed clinic prices or confirmation of legal availability.
  • Peptide therapy costs depend on the peptide, dose and program length.
  • A doctor prescribed program can include screening, clinician guided dosing, monitoring, sourcing verification and cold chain delivery where legally eligible and appropriate, safeguards not assured by a research vial purchase.
  • Products labelled “research use only” are not approved for human use.
  • Your exact program cost is confirmed free during a doctor consultation.

Understand what a supervised program includes before you decide.

Free online doctor consultation

Online across Thailand, or in person at our Chiang Mai clinic. Delivery nationwide.

Before the price

What peptide therapy is and how it works

Peptide therapy is not one standard treatment. It is a clinical conversation about a specific goal, your health history, current medicines and whether an available treatment is appropriate for you. A program may involve consultation, prescribed treatment where appropriate, clear administration guidance and follow-up.

Peptides Thailand has one physical clinic in Chiang Mai. People elsewhere in Thailand can access an online doctor consultation and cold-chain delivery nationwide. That distinction matters when comparing a program with an online purchase of a vial alone.

The range explained

What drives the cost

The treatment plan

Different peptides, forms and intended uses have different supply and handling requirements.

Dose and duration

A plan changes with the dose, titration and length of the program.

Clinical assessment

Consultation helps establish whether a treatment is appropriate and what safeguards may be needed.

Delivery and follow-up

Cold-chain logistics, access to clinical support and follow-up are part of a doctor-supervised route.

Part A · Indicative program costs

Doctor-prescribed monthly program ranges

Indicative Thailand market ranges as of 2026, not fixed clinic prices. The actual cost depends on the peptide, dose, and program length and is confirmed free during consultation.

PeptideTypical useMonthly program
BPC 157 Healing, gut, recovery฿21,000 to ฿42,000
Semaglutide Weight loss฿8,000 to ฿15,000+
Tirzepatide Weight loss฿15,000 to ฿28,000+
RetatrutideInvestigational Weight loss฿15,000 to ฿45,000
TB 500 / Thymosin Beta 4 Recovery, injury; separate molecules grouped for this market range฿7,200 to ฿21,000
CJC 1295 Growth hormone support฿3,500 to ฿7,000
Ipamorelin Growth hormone support฿3,500 to ฿7,000
GHK Cu Skin, anti-aging฿4,400 to ฿7,000
PT 141 Libido฿5,000 to ฿14,000
Tesamorelin Fat loss, metabolic฿12,000 to ฿14,000

These are indicative Thailand market ranges, not fixed clinic prices. Whether any molecule, formulation or program is legally available or clinically appropriate depends on its regulatory status and individual assessment. Retatrutide is investigational and is not approved for routine treatment. Its inclusion is not an offer or proof of legal availability. Discuss approved alternatives with a doctor.

A clear next step

Get your exact program cost from a doctor. Book a free consultation.

Ranges above are indicative. Your real cost depends on the peptide, dose and program, confirmed free with a doctor.

Safety and optimal outcomes start with a doctor specialised in Peptides.

Physician-led care Free online doctor consultation Book a free consultation

Online across Thailand, or in person at our Chiang Mai clinic. Delivery nationwide.

Part B · What the difference includes

Research-grade ecommerce and a doctor-prescribed program

A lower price can be meaningful, especially when you are paying out of pocket. This comparison focuses on what is documented, what needs verification and which safeguards come with clinical care.

FactorResearch-grade ecommerceDoctor-prescribed program
PriceA fraction of the costReal numbers above
Intended useLabeled “research only, not for human use”Clinician assessment and prescription when appropriate
Purity, potency, sterility verifiedNot assured for human useDocumented sourcing checks and handling safeguards
DosingSelf-guided, easy to get wrongSet and titrated by a clinician when appropriate
Screening for contraindicationsNot built into the purchaseCompleted before a program is considered
Monitoring and side-effect supportNot included with the purchaseClinical follow-up and support included
Product traceability and recallNot assuredDocumented and verified where available
DeliveryBuyer arrangesCold-chain delivery nationwide where legally eligible and appropriate

A prescription does not itself guarantee purity, sterility or an absence of risk. Screening and oversight add safeguards rather than guarantees.

For people already self-sourcing

You deserve clear information, not a lecture

If you already source your own peptides, you are not alone, and the reasons make sense. Clinics can be expensive and vague about pricing, access can feel limited, and you may want control over your protocol. The problem is not that you are careless or uninformed.

It is that even a careful person cannot verify what is actually in an unregulated vial, confirm its sterility or identify every interaction or personal contraindication from the outside. That is an information gap research alone cannot close.

Research use only is not the same as off-label care

Products labelled for research use only are not approved for human use. The FDA explains that off-label use concerns an approved drug used differently from its approved label, so a research vial is not merely off-label. In its semaglutide and GLP-1 safety information, the FDA warns that unapproved products have not been reviewed for quality, safety or effectiveness, and notes risks including dosing errors, fraudulent labels and inadequate refrigerated shipping.

A small independent study of online peptides found purity and content mismatches in its samples and elevated endotoxin in one sample, while reporting no viable microbes detected. That limited study does not describe all products, but it illustrates why label claims alone are not a clinical quality check.

Unsupervised protocols remove medical safeguards

Without a clinical assessment, there may be no check for contraindications or medicine interactions, no support with dosing, titration, reconstitution or injection errors, and no clinician to evaluate a reaction or decide whether monitoring is needed. The FDA’s semaglutide and GLP-1 safety information documents dosing errors with unapproved products, although that source is specific to semaglutide and GLP-1 medicines. Self-treatment can also mask or delay assessment of an underlying condition. These are potential safeguards that depend on the individual program, not guarantees of safety or outcome.

Sources: FDA on unapproved semaglutide and GLP-1 products, FDA on off-label use, Thai FDA product registration.

What supervision adds

How doctor supervision changes the decision

The higher program cost is not simply a different product. For legally eligible treatment, it can pay for time to review your history and medicines, clarify the treatment goal, set and adjust dosing when appropriate, document sourcing and handling, arrange cold-chain delivery and provide a route for side-effect support.

Those measures cannot remove every risk or promise an outcome. They give you a clearer process for deciding whether to start, change or stop a program with a clinician involved.

How to start

Start with your questions

01

Share your goal and current protocol

02

Discuss relevant health history and medicines

03

Receive a clear cost and next-step discussion

Start with a free online doctor consultation.

Online across Thailand, or in person at our Chiang Mai clinic. Delivery nationwide.

Free online doctor consultation

Cost guide questions

How much does peptide therapy cost in Thailand?
Doctor-supervised peptide therapy in Thailand typically runs from about ฿3,500 to ฿45,000 per month, depending on the peptide, dose and program length. The published ranges are indicative market ranges rather than fixed clinic prices, and the exact cost is confirmed free during a doctor consultation.
Why is clinic peptide therapy more expensive than research peptides?
The difference is not only the vial. A doctor-prescribed program can include clinical screening, a prescription when appropriate, dosing and titration guidance, monitored follow-up, product traceability and cold-chain delivery. Research vials may cost a fraction of the price, but those safeguards are not assured.
Is it safe to buy research-grade peptides?
Research-grade products labelled for research use only are not approved for human use and are not simply an off-label use of an approved drug. The FDA warns that unapproved products have not been reviewed for quality, safety or effectiveness. A small independent study found purity and content mismatches in sampled online peptides and elevated endotoxin in one sample, but this limited study does not describe every product.
What are the risks of using peptides without a doctor?
Without clinical assessment, a person may miss contraindications or medicine interactions, make dosing, titration, reconstitution or injection errors, and have no clinician to evaluate a reaction or decide whether monitoring is needed. Self-treatment can also delay assessment of an underlying condition. Medical oversight adds safeguards, but cannot guarantee a particular outcome or remove every risk.
Is peptide therapy legal in Thailand?
Thailand requires pharmaceutical products to be registered and approved through the Thai FDA process. Whether a particular treatment is appropriate or available depends on the product, regulatory status and individual clinical assessment. Retatrutide and other unapproved research molecules are not offers or proof of legal availability. A doctor can discuss approved alternatives and the options relevant to you.
Consultation